Steroid Expert Witnesses in Georgia

This medical toxicologist is a fellow of the American College of Medical Toxicology and an adjunct associate professor of Toxicology at a respected Florida college of public health. In addition to an MD obtained in Mexico, he earned his doctorate in Toxicology from the University of Minnesota, with a Master's degree in Public Health from the University of Texas at Houston. He was a Poison Specialist Certified with the American Association of Poison Control Centers for more than twenty years and is an active member of the American Academy of Clinical Toxicology and the Society of Toxicology. He has over a quarter century of experience performing medical toxicological assessments on individuals and communities exposed to toxic substances such as pesticides, heavy metals, industrial and environmental chemicals substances both at the community level as well as occupationally.

This highly experienced expert in drug discovery and drug development earned his PhD in Pharmacology from Yale University and thereafter completed a postgraduate fellowship at the University of Michigan. He previously served as the Chief Scientific Officer of Adherex Technologies, International Vice President of Cancer Research at Glaxo Wellcome (now GSK) and Associate Division Director of Experimental Therapy at Burroughs Wellcome. He is a member of the American Chemical Society, the American Association for Cancer Research, and the American Society of Clinical Oncology. He has extensive experience in preclinical and clinical research and legal consulting.

This expert has 15 years of experience in clinical pharmacotherapy. He received his PharmD from Campbell University School of Pharmacy and completed his residency in pharmacy practice at Wake Forest University's Baptist Medical Center. He is board certified as a pharmacotherapy specialist. He began his career as a decentralized clinical pharmacist at Wake Forest University before accepting a position as an assistant professor of clinical pharmacy practice and the anticoagulation clinic director at Auburn University. He then went on to be an assistant professor, and eventually associate professor, of clinical pharmacy practice at East Tennessee State University. This expert is heavily involved in pharmacological research, having authored several peer-reviewed articles and presenting on numerous posters at various pharmacy conferences. He currently serves as the vice chair of pharmacy practice and professor of clinical pharmacy practice at a pharmacy program at a Tennessee medical school.

This expert has extensive experience in psychiatric pharmacy. He completed his BS in biology and chemistry and his PharmD from the University of Wyoming. He then completed two residencies in pharmacy and ambulatory care from the VA Black Hills Healthcare System. Board-certified as an ambulatory care pharmacist, pharmacotherapy specialist, and psychiatric pharmacist, this expert is active in his field as a member of the American College of Clinical Pharmacy, the Academy of Integrative Pain Management, and the College of Psychiatric and Neurologic Pharmacists. He previously served as a pharmacist at the VA Black Hills Healthcare System and as a clinical assistant professor of pharmacy at the South Dakota State University. He was also a clinical pharmacy specialist t the VA Black Hills Healthcare System and the Sheridan VA Medical Center. This expert currently works as a consultant for a biotech company and as the associate chief and pharmacy specialist at a VA medical center in Florida.

This highly qualified expert has years of experience in the field of neuropharmacology. He received his PhD degree from the University of California, Santa Barbara, and completed his fellowship training at Harvard University. He is a member of various professional associations, including the American Society of Pharmacology and Experimental Therapeutics and the American Chemical Society. He has published 250+ peer reviewed journal articles and has 51+ US issued patents that focus particularly on neurological studies. He also serves as the editor-in-chief for ACS Chemical Neuroscience, lectures both nationally and internationally and has received multiple honors for his outstanding work, including the John J. Abel award in pharmacology. He is the former co-director of the Synthesis Facility at the Vanderbilt Institute of Chemical Biology and the former senior organic chemist at Eli Lilly & Co. Currently, he is a professor of pharmacology and chemistry at a major university, where he is also the director of medicinal chemistry and DMPK at the Center for Neuroscience Drug Discovery. Additionally, he is the director of drug discovery at a major science institute in Tennessee.

This qualified expert of Addiction Psychiatry completed his undergrad and MD in Canada at the McGill University. He completed his post-doc Residency and Fellowship in Psychiatry and Pharmacology in Canada at the University of Toronto. He is Board Certified in the US in Psychiatry & Neurology and in Addiction Psychiatry. He is a member of multiple Addiction Psychiatry Medical Associations and has published 200+ Publications on Addiction Psychiatry Research. He is currently a Professor of Psychiatry at a Top Medical University, the Director of a Top University's Addiction Center, and is the Chief Psychiatrist and Associate Medical Director at a Top University Hospital.